A case of Gemella morbillorum endocarditis Sir, We report a case of Gemella morbillorum endocarditis. A 75-year-old man was admitted to hospital for investigation of weight loss and lassitude of two months duration. He had a history of rhematic fever as a child. Examination revealed a temperature of 38.5'C, mild ankle oedema and a pansystolic murmur radiating to the axilla. There were no other signs of endocarditis. He had a haemoglobin of 9.3 g/dl, white cell count of 9.7 x 109/l and an erythrocyte sedimentation rate of48 mm/h. An echocardiogram revealed mitral valve vegetations with regurgitation. A diagnosis ofendocarditis was made, three sets of blood cultures were taken and he was started on benzylpenicillin 1.2 g iv 4 hourly and gentamicin 80 mg iv 12 hourly. His temperature returned to normal after 24 hours. At 48 hours all three sets of blood cultures grew G morbillorum (confirmed by the Streptococcal Reference Laboratory). The organism proved sensitive to penicillin on disc testing but failed to survive subculture for further sensitivity studies. After 24 days of benzylpenicillin a bright red maculopapular rash appeared over the patient's trunk and legs and a leucopenia of 1.8 x 109/1 was noted. This was consistent with an allergic reaction and treatment was stopped. His temperature rose to 39°C within 48 hours. Further cultures were taken and he was given teicoplanin. After the first dose of this he became dizzy, wheezy and breathless. His blood pressure fell to 90/60 mmHg. He was given iv hydrocortisone, chlorpheniramine and salbutamol. In view of his reaction to teicoplanin we decided not to risk treatment with vancomycin and opted instead for rifampicin 600 mg orally 12 hourly and erythromycin 500 mg orally 6 hourly. The organism had appeared sensitive to both these drugs on disc testing. The 
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Gemella haemolysans prosthetic valve endocarditis
Sir, We report a case of prosthetic valve endocarditis caused by Gemella haemolysans in a 34-year-old man who has had four cardiac operations including valve replacement for complex heart disease. We believe this to be the first reported case in the UK.
A 34-year-old man presented with a short history ofmyalgia, fever, and general malaise. He recognised these symptoms as possibly being endocarditis, having had four previous episodes. The only positive findings on examination were three sites ofasymptomatic dental sepsis. Transoesophageal echocardiography showed a lesion on his prosthetic aortic valve suggestive of a vegetation. G haemolysans was isolated from several blood cultures. G haemolysans is sensitive to penicillin and synergy with gentamicin has been demonstrated.' This option was not open to us as, three years previously, the patient had profound neutropenia, including bone marrow eosinophilia, during another episode of endocarditis treated by benzylpenicillin and gentamicin. The neutropenia resolved on withdrawal of benzylpenicillin. Based on blood culture sensitivities treatment was begun with intravenous cefuroxime and tobramycin; the latter was stopped after 14 days and oral ciprofloxacin substituted. After a further five days the cefuroxime was stopped because the patient developed a profound neutropenia, and oral erythromycin started. Marrow examination revealed a decreased number of myeloid cells, with very little development beyond the myelocyte stage, and an increased number of eosinophils. Erythroid cells and megakaryocytes were normal. The neutrophil count recovered spontaneously over the next four days.
Six cases of endocarditis due to G haemolysans have been reported since 1982,2 but only one case of prosthetic valve endocarditis.3
The recommended treatment is a combination of penicillin and aminoglycoside.'"2 In this case management of the patient was complicated by drug-induced neutropenia forcing a change in therapy. Despite this the patient made a good recovery and remains well with no deterioration in his prosthetic valve function. The term 'aplastic anaemia' refers to conditions in which a markedly hypocellular bone marrow results in pancytopaenia (anaemia, leukopaenia, and thrombocytopaenia).' However, from a terminological point of view, aplastic anaemia means anaemia due to aplastic bone marrow where this anaemia in the medical literature is termed pure red cell aplasia. So I suggest that aplastic anaemia should be used only when the aplasia involves a selective failure in the production of erythroid elements in the bone marrow causing anaemia and reticulocytopaenia. When pancytopaenia due to bone marrow aplasia is present, instead of the classic term aplastic anaemia, the term aplastic pancytopaenia should be used; it is both more descriptive, and more suitable. 
